WebBOOSTRIX product monograph (PDF - 448 KB) Healthcare professional information: 1 May 2024 - Important Safety Information (PDF - 176 KB) for several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing; GSK. This website is intended for visitors looking for information on GSK Canada. WebThe NDC Packaged Code 58160-842-52 is assigned to a package of 10 syringe in 1 carton / .5 ml in 1 syringe (58160-842-43) of Boostrix, a vaccine label labeled by Glaxosmithkline Biologicals Sa. The product's dosage form is suspension and is administered via intramuscular form.
DailyMed - BOOSTRIX- tetanus toxoid, reduced diphtheria …
WebDec 1, 2024 · pain, redness, or swelling where the shot was given; headache or tiredness; body aches; or. fever. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967. WebBOOSTRIX is a turbid white suspension for injection. Upon storage a white deposit and clear supernatant can be observed. This is a normal finding. 4. CLINICAL PARTICULARS 4.1 Indications BOOSTRIX is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals aged four years and older (see Section 4.2 DOSE AND ... pure sharpstone
Package leaflet: Information for the user - medicines
WebSep 16, 2024 · Boostrix is a prescription medicine used as an immunization booster against tetanus, diphtheria, and pertussis in a single dose. Boostrix may be used alone or with … WebFind patient medical information for Boostrix Tdap intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. WebBoostrix-IPV is indicated for booster vaccination against diphtheria, tetanus, pertussis and poliomyelitis of individuals from the age of three years onwards (see section 4.2). … section 530b